BioNTech veteran secures $25M seed round for virtual cancer surveillance startup

A new virtual cancer surveillance company has closed a $25 million seed round, with the funding led by investors attracted to its novel approach to monitoring tumors.

The company is headed by Ryan Richardson, who previously served as chief strategy officer at BioNTech and played a key role in the development of the company's Covid-19 vaccine before turning his focus back to oncology.

The startup aims to use digital tools and data analytics to track cancer progression in real time, allowing clinicians to adjust treatments more quickly.

The injection of capital gives the firm resources to expand its platform and could accelerate the adoption of remote monitoring technologies across the oncology sector.